Oxygen Transport in Vivo by Means of Perfluorochemical Preparations

New England Journal of Medicine

Volumn 307, Issue 5, 1982, Pages 304-306

  Geyer, Robert P ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOSOL DA; HYDROXYETHYLCELLULOSE; OXYGEN; PERFLUORO COMPOUND; PERFLUORODECALIN; PERFLUOROTRIBUTYLAMINE; POLOXAMER;

BLOOD SUBSTITUTION; BLOOD TRANSFUSION; DRUG ANALYSIS; DRUG RESEARCH; OXYGEN TRANSPORT;

EID: 0019976642     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198207293070509     Document Type: Editorial

References (11)

1. Howlett S., Dundas D., Sabiston D.C. Jr. Fluid fluorocarbon as oxygenator in experimental extracorporeal circulation. Arch Surg. 1965; 91:643-645
2. Clark L.C. Jr., Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science. 1966; 152:1755-1756
3. Sloviter H.A., Kamimoto T. Erythrocyte substitute for perfusion of brain. Nature. 1967; 216:458-460
4. Geyer R.P., Monroe R.G., Taylor K. Survival of rats having red cells totally replaced with emulsified fluorocarbon. Fed Proc. 1968; 27:384.
5. Geyer R.P. “Bloodless” rats through the use of artificial blood substitutes. Fed Proc. 1975; 34:1499-1505
6. Clark L.C. Jr., Wesseler E.P., Miller M.L., Kaplan S. Ring versus straight chain perfluorocarbon emulsions for perfusion media. Microvasc Res. 1974; 8:320-340
7. Geyer R.P. Perfluorochemical blood replacement preparations. Proceedings of the IVth International Symposium on PFCB Subst., Kyoto, Japan, October 1978. Amsterdam: Excerpta Medica, 1979: 3-32.
8. Naito R., Yokoyama K. Supplement to PFC blood substitutes (FC-43 emulsion, fluosol-DA 20% and 35%), as an oxygen carrying colloidal blood substitute. Osaka, Japan, Green Cross Technical Information Service, publication no. 7, July 30, 1981.
9. Makowski H., Tentschev P., Frey R., Necek S.T., Bergmann H., Blauhut B. Tolerance of an oxygen-carrying colloidal plasma substitute in human beings. Proceedings of the IVth International Symposium on PFCB Subst., Kyoto, Japan, October 1978. Amsterdam: Excerpta Medica, 1979: 47-54.
10. Ohyanagi H., Toshima K., Sekita M., et al. Clinical studies of perfluorochemical whole blood substitutes: safety of Fluosol-DA (20%) in normal human volunteers. Clin Ther. 1979; 2:306-312
11. Tremper K.K., Friedman A.E., Levine E.M., Lapin R., Camarillo D. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, fluosol-DA. N Engl J Med. 1982; 307:277-283